Petlife Pharmaceuticals (PTLF) Stock Statistics & Valuation Metrics

Petlife Pharmaceuticals has a market cap or net worth of $22.21K. The enterprise value is $682.60K.

Petlife Pharmaceuticals has 222,120,650 shares outstanding. The number of shares has decreased by -2.65% in one year.

Petlife Pharmaceuticals’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Petlife Pharmaceuticals is ―. Petlife Pharmaceuticals’s PEG ratio is >-0.00001.

In the last 12 months, Petlife Pharmaceuticals had revenue of 0.00 and earned -23.26M in profits. Earnings per share was -0.33.

In the last 12 months, operating cash flow was -261.90K and capital expenditures 0.00, giving a free cash flow of -261.90K billion.

Petlife Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―

Petlife Pharmaceuticals upcoming earnings date is ―, ―.

Petlife Pharmaceuticals as a current ratio of ―, with Debt / Equity ratio of -51.91%

In the past 12 months, Petlife Pharmaceuticals has paid 0.00 in taxes.

Petlife Pharmaceuticals EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Petlife Pharmaceuticals has $7.86K in cash and marketable securities with $801.65K in debt, giving a net cash position of -$793.80K billion.

Gross margin is 0.00%, with operating margin of ―, and net profit margin of ―.

The average price target for Petlife Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―